Intellipharmaceutics International Inc. Quarterly Net Cash Provided by (Used in) Investing Activities in USD from Q3 2020 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Intellipharmaceutics International Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q3 2020 to Q3 2023.
  • Intellipharmaceutics International Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending August 31, 2023 was $0.000.
  • Intellipharmaceutics International Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $500K.
  • Intellipharmaceutics International Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was $0.000, a 100% decline from 2020.
  • Intellipharmaceutics International Inc. annual Net Cash Provided by (Used in) Investing Activities for 2020 was $25.3K.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $0 $0 Jun 1, 2023 Aug 31, 2023 6-K 2023-10-16
Q2 2023 $0 -$500K -100% Mar 1, 2023 May 31, 2023 6-K 2023-09-26
Q3 2022 $0 $0 Jun 1, 2022 Aug 31, 2022 6-K 2023-10-16
Q2 2022 $500K +$500K Mar 1, 2022 May 31, 2022 6-K 2023-09-26
Q3 2021 $0 -$4.93K -100% Jun 1, 2021 Aug 31, 2021 6-K 2022-10-14
Q2 2021 $0 Mar 1, 2021 May 31, 2021 6-K 2022-07-21
Q3 2020 $4.93K Jun 1, 2020 Aug 31, 2020 6-K 2021-10-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.